Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Shock (Augusta, Ga.)|May 23, 2008
Recombinant factor VIIa reduces rebleed hemorrhage volume in a swine aortotomy model: a randomized double-blinded studyNeil R McMullin, Ulla Hedner, Mirella Ezban, et al.Journal of Immunotoxicology|November 6, 2019
Formation and glomerular deposition of immune complexes in mice administered bovine serum albumin: Evaluation of dose, frequency, and biomarkersLykke Boysen, Birgitte M Viuff, Lone H Landsy, et al.Biologicals : Journal of the International Association of Biological Standardization|June 16, 2019
Generic immune complex assay for detection of murine anti-drug-antibodies in complex with human IgGLykke Boysen, Anne M E Sprinkel, Brian Lauritzen, et al.Toxicologic Pathology|April 23, 2020
Formation and Glomerular Deposition of Immune Complexes in Mice Administered Human Antibodies: Evaluation of Dose, Frequency, and BiomarkersLykke Boysen, Birgitte M Viuff, Lone H Landsy, et al.Thrombosis Research|January 8, 2014
Target-mediated clearance and bio-distribution of a monoclonal antibody against the Kunitz-type protease inhibitor 2 domain of Tissue Factor Pathway InhibitorLene Hansen, Lars Christian Petersen, Brian Lauritzen, et al.Journal of Visualized Experiments : Jove|October 18, 2021
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A MiceAriadna Carol Illa, Sarah Baumgarten, Dennis Danielsen, et al.Journal of Thrombosis and Haemostasis : JTH|February 22, 2022
A novel next-generation FVIIIa mimetic, Mim8, has a favorable safety profile and displays potent pharmacodynamic effects: Results from safety studies in cynomolgus monkeysBrian Lauritzen, Mads Bjelke, Olle Björkdahl, et al.Molecular Therapy. Methods & Clinical Development|December 9, 2025
Nonclinical toxicity study duration in AAV gene therapy development: Evidence from industry survey supports adequacy of short-term assessmentsBasel T Assaf, David Edwards, Shawn Jay Berens, et al.Molecular Therapy. Methods & Clinical Development|October 7, 2020
Nonclinical Studies that Support Viral Vector-Delivered Gene Therapies: An EFPIA Gene Therapy Working Group PerspectiveMichael W Bolt, Laurence O Whiteley, Jessica L Lynch, et al.Blood|May 8, 2012
Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia modelIda Hilden, Brian Lauritzen, Brit Binow Sørensen, et al.Pageof 2